Durvulumab-induced rheumatoid arthritis: A case report (Translation: The University of Toledo Journal of Medical Sciences, 2023)
Keywords: Oncology; Checkpoint inhibitors; immunotherapy; Durvulumab; Rheumatoid arthritis